Technical Analysis for APRE - Aprea Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 36.89 -6.30% -2.48
APRE closed down 6.3 percent on Friday, December 13, 2019, on 1.15 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
See historical APRE trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -6.30%
Expansion Breakout Bullish Swing Setup -6.30%
Pocket Pivot Bullish Swing Setup -6.30%
Older signals for APRE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Aprea Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of novel anticancer compounds that reactivate the tumor suppressor protein, p53. The company's lead drug candidate APR-246, a small molecule p53 reactivator, is in clinical development for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), as well as additional hematologic and solid tumor malignancies. It has commenced a Phase 3 clinical trial in p53 mutant MDS and completed enrollment in a Phase 1b/2 clinical trial in p53 mutant MDS and AML with APR-246 and azacitidine; and additional Phase 1/2 trials of APR-246 in MDS and AML in combination with approved anti-cancer therapies, as well as developing next generation p53 reactivators. The company was founded in 2003 and is based in Boston, Massachusetts.
Biopharmaceutical Cancer Tumor Acute Myeloid Leukemia Cancer Therapies Myelodysplastic Syndrome Lactams Myelodysplastic Syndromes Anti Cancer Therapies P53 Tumor Suppressor Tumor Suppressor Genes

Is APRE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 44.2999
52 Week Low 15.1
Average Volume 108,291
200-Day Moving Average 0.00
50-Day Moving Average 25.00
20-Day Moving Average 28.01
10-Day Moving Average 29.61
Average True Range 3.42
ADX 35.15
+DI 40.95
-DI 7.32
Chandelier Exit (Long, 3 ATRs ) 34.03
Chandelier Exit (Short, 3 ATRs ) 32.14
Upper Bollinger Band 37.15
Lower Bollinger Band 18.87
Percent B (%b) 0.99
BandWidth 65.26
MACD Line 2.77
MACD Signal Line 1.48
MACD Histogram 1.2963
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.71
Resistance 3 (R3) 43.36 42.06 41.74
Resistance 2 (R2) 42.06 40.58 41.74 41.42
Resistance 1 (R1) 39.48 39.66 38.83 38.83 41.10
Pivot Point 38.18 38.18 37.85 37.86 38.18
Support 1 (S1) 35.59 36.69 34.94 34.95 32.68
Support 2 (S2) 34.29 35.78 33.97 32.36
Support 3 (S3) 31.71 34.29 32.04
Support 4 (S4) 31.07